VASCO PHARMA
ActiveVASCO PHARMA is a financial institution; the bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €878k and a net result of €60k. Equity is growing by ~2.6% per year across the filed fiscal years. Its solvency ranks better than 42% of 5487 sector peers (fiscal year 2025). The company has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals.
Signals
Three signals. The signal on the left, the evidence on the right.
○neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
17 d early
2024
on the day
2023
1 d early
2022
3 d late
2021
67 d late
2020
19 d early
2019
25 d late
← before the deadline
after the deadline →
neutral · The next deadline is still running
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today.
Companies Code · seven monthsPosition in the running window
12-09-2026 today31-12-2026 close31-07-2027 deadline
Financials · fiscal year 2025, abbreviated schema
Equity
€878k▲ 7.2%
2024 · €818k
2018: €360k
2019: €780k
2020: €790k
2021: €841k
2022: €994k
2023: €827k
2024: €818k
2018 → 2025
Net result
€60k
2024 · €-9k
2018: €-3k
2019: €577k
2020: €10k
2021: €51k
2022: €153k
2023: €-167k
2024: €-9k
2018 → 2025
Total assets
€2.07M▼ 6.2%
2024 · €2.21M
2018: €2.79M
2019: €2.22M
2020: €2.83M
2021: €2.70M
2022: €2.73M
2023: €2.39M
2024: €2.21M
2018 → 2025
Solvency
42.4%▲ 5.3pp
2024 · 37.1%
2018: 12.9%
2019: 35.1%
2020: 27.9%
2021: 31.2%
2022: 36.5%
2023: 34.7%
2024: 37.1%
2018 → 2025
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line20212022202320242025Trend
Equity€841k-€994k▲ 18.2%€827k▼ 16.8%€818k▼ 1.1%€878k▲ 7.2%
Operating result€71k-€213k▲ 200%€211k▼ 1.3%€66k▼ 68.5%€114k▲ 72.4%
Net result€51k-€153k▲ 198%€-167k€-9k▲ 94.7%€60k
Turnover and EBIT margin not published: the abbreviated schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2025; 2025 is 72% above 2024.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €2.07M
Fixed assets
€2.05M▼ 2.7%
Current assets
€22k▼ 78.9%
Equity and liabilities €2.07M
Equity
€878k▲ 7.2%
Provisions
€55k▼ 7.1%
Debt
€1.14M▼ 14.4%
The debt ratio falls from 60.3% to 55.0%: equity grows while debt is paid down.
Key figures and ratios
Solvency
42.4%▲
2024 · 37.1%
ROE
6.8%▲
2024 · -1.1%
ROA
2.9%▲
2024 · -0.4%
Debt
€1.14M▼
2024 · €1.33M
Debt ≤ 1 year
€308k▼
2024 · €396k
Debt > 1 year
€828k▼
2024 · €921k
Income taxes
€24k▲
2024 · €9k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2025 against 2024
Balance sheet
Code20242025
Assets
Total assets20/58€2.21M€2.07M▼
Fixed assets21/28€2.11M€2.05M▼
Tangible fixed assets22/27€1.19M€1.16M▼
Land and buildings22€1.19M€1.16M▼
Plant, machinery and equipment23€2k€927▼
Furniture and vehicles24€0-
Financial fixed assets28€911k€892k▼
Current assets29/58€102k€22k▼
Amounts receivable after more than one year29€0-
Other amounts receivable291€0-
Amounts receivable within one year40/41€0€850▲
Other amounts receivable41€0€850▲
Current investments50/53€0-
Cash at bank and in hand54/58€102k€20k▼
Deferred charges and accrued income490/1€0€438▲
Equity and liabilities
Total equity and liabilities10/49€2.21M€2.07M▼
Equity10/15€818k€878k▲
Contributions10/11€295k€295k=
Reserves13€523k€582k▲
Tax-exempt reserves132€114k€106k▼
Distributable reserves133€409k€476k▲
Profit (loss) carried forward14-€0
Provisions and deferred taxes16€59k€55k▼
Deferred taxes168€59k€55k▼
Amounts payable17/49€1.33M€1.14M▼
Amounts payable after more than one year17€921k€828k▼
Financial debts170/4€921k€828k▼
Amounts payable within one year42/48€396k€308k▼
Current portion of amounts payable after more than one year42€118k€127k▲
Financial debts43€4k€5k▲
Credit institutions430/8€4k€5k▲
Trade debts44€14k€7k▼
Suppliers440/4€14k€7k▼
Taxes, remuneration and social security45€16k€13k▼
Taxes450/3€16k€13k▼
Other amounts payable47/48€244k€156k▼
Accrued charges and deferred income492/3€13k€3k▼
Income statement
Code20242025
Non-recurring operating income76A€10k€0▼
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€37k€37k▲
Other operating charges640/8€4k€5k▲
Non-recurring operating charges66A€10k€19k▲
Gross operating margin9900€118k€175k▲
Operating profit (loss)9901€66k€114k▲
Financial income75/76B€19k€0▼
Recurring financial income75€19k€0▼
Financial charges65/66B€90k€34k▼
Recurring financial charges65€47k€34k▼
Non-recurring financial charges66B€43k€0▼
Profit (loss) for the period before taxes9903€-4k€80k▲
Transfer from deferred taxes780€4k€4k=
Income taxes67/77€9k€24k▲
Profit (loss) for the period9904€-9k€60k▲
Transfer from tax-exempt reserves789€8k€8k=
Profit (loss) for the period to be appropriated9905€-674€68k▲
Appropriation of the result
Profit (loss) to be appropriated9906€-674€68k▲
Transfer from equity791/2€674€0▼
Transfer to equity691/2-€67k
To other reserves6921-€67k
Profit to be distributed694/7-€833
Return on contributions (dividend)694-€833
Social balance
Average headcount (FTE)90870.00.0=
The notes to these accounts (21 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
Next filing, fiscal year 2026, expected by
2026
14-07
NBB filing
Annual accounts filed
fiscal year 2025 · abbreviated schema
2025
31-12
Financial
Back to profitnet €60k
Net result €60k after 2 loss-making years.
31-07
NBB filing
Annual accounts filed
fiscal year 2024 · abbreviated schema
2024
30-07
NBB filing
Annual accounts filed
fiscal year 2023 · abbreviated schema
2023
31-12
Financial
Weakest financial yearnet €-167k ▼209%
Net result drops to €-167k, the lowest in the series; recovery starts the following year.
03-08
NBB filing
Annual accounts filed
fiscal year 2022 · abbreviated schema · 3 days late
2022
06-10
NBB filing
Annual accounts filed
fiscal year 2021 · abbreviated schema · 67 days late
2021
12-07
NBB filing
Annual accounts filed
fiscal year 2020 · abbreviated schema
2020
25-08
NBB filing
Annual accounts filed
fiscal year 2019 · abbreviated schema · 25 days late
2019
31-12
Financial
Back to profitnet €577k
Net result €577k after one loss-making year.
31-12
Financial
Liquidity times 8current ratio 1.38
Current ratio from 0.18 to 1.38; short-term debt falls from €1.09M to €587k.
31-12
Financial
Equity above €500kEq €780k ▲117%
Equity rises from €360k to €780k.
16-07
NBB filing
Annual accounts filed
fiscal year 2018 · abbreviated schema
2018
01-10
NBB filing
Annual accounts filed
fiscal year 2017 · full schema · 62 days late
2017
14-07
NBB filing
Annual accounts filed
fiscal year 2016 · full schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
9 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Kontich · 1 establishment unit since 2005
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Kontichhof 152550 KontichGround area
3,232 m²
Building footprint
232 m²
Volume, LiDAR
1,877 m³
Parcel 11024A0284/00C000, Flanders · tallest building 11.9 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
Vasco Pharma
since 20052.145.050.575
1 parcel
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 11024A0284/00C000 | Flanders | 3,231 m² | 1 · 232 m² | 11.9 m · 3 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
1 of these parcels carry protected heritage (source: regional heritage registers, Onroerend Erfgoed / patrimoine.brussels).
Similar companies · same sector, comparable size
HOMYAR
BE 0754.971.190
Meise · Eq €877k
DE SPECHT
BE 0465.956.326
Moorslede · Eq €877k
Livewire
BE 0767.582.576
Vosselaar · Eq €878k
G-G IMMO
BE 0772.686.954
Zoersel · Eq €878k
GLAD HOSPITALITY
BE 0656.962.687
Oostende · Eq €879k
Of 24,641 companies in sector 64210 we hold annual accounts for 19,693. 12,945 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded25-11-2004
Fiscal year end31-12
Activities, NACEBEL
64200Holdings
64210Activities of holding companies
74151
74855
82100Office administrative and support services
82110Office administrative, office support and other business support activities
Sources
Crossroads Bank for EnterprisesNational Bank · 21 filingsAddress and cadastre registers
Data from official sources, last processed on 12-09-2026. Scores and ratios are computed by Checked and are not a credit decision.